Slika omota

Consensus quality indicators for monitoring multiple sclerosis

Summary: Multiple sclerosis (MS) as a chronic, degenerative autoimmune disease of the central nervous system has a longitudinal and heterogeneous course with increasing treatment options and risk profiles requiring constant monitoring of a growing number of parameters. Despite treatment guidelines,...

Spremljeno u:

Bibliografski detalji
Glavni autori:	Isabel Voigt (Autor), Stefanie Fischer (Autor), Undine Proschmann (Autor), Urszula Konofalska (Autor), Peggy Richter (Autor), Hannes Schlieter (Autor), Thomas Berger (Autor), Sven G. Meuth (Autor), Hans-Peter Hartung (Autor), Katja Akgün (Autor), Tjalf Ziemssen (Autor)
Format:	Knjiga
Izdano:	Elsevier, 2024-05-01T00:00:00Z.
Teme:	article
Online pristup:	Connect to this object online.
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti

Challenges in monitoring the quality of care in multiple sclerosis-authors' reply
od: Isabel Voigt, i dr.
Izdano: (2024)

The need for a strategic therapeutic approach: multiple sclerosis in check
od: Hernan Inojosa, i dr.
Izdano: (2022)

Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting
od: Francisco Alejandro Rodriguez-Leal, i dr.
Izdano: (2019)

Long-term effects of siponimod on cardiovascular and autonomic nervous system in secondary progressive multiple sclerosis
od: Victor Constantinescu, i dr.
Izdano: (2024)

Use and Acceptance of Electronic Communication by Patients With Multiple Sclerosis: A Multicenter Questionnaire Study
od: Haase, Rocco, i dr.
Izdano: (2012)

All together now - patient engagement, patient empowerment, and associated terms in personal healthcare
od: Emily Hickmann, i dr.
Izdano: (2022)

Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab
od: Tjalf Ziemssen, i dr.
Izdano: (2024)

The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study
od: Ness, Nils-Henning, i dr.
Izdano: (2020)

"Der ,Digitale Zwilling' kann die MS-Versorgung wirklich verbessern"
od: Univ.-Prof. Dr. med. Tjalf Ziemssen, i dr.
Izdano: (2023)

Cognitive assessment in patients with multiple sclerosis: A Spanish consensus
od: Yolanda Higueras, i dr.
Izdano: (2022)

A Physician-Completed Digital Tool for Evaluating Disease Progression (Multiple Sclerosis Progression Discussion Tool): Validation Study
od: Ziemssen, Tjalf, i dr.
Izdano: (2020)

Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine
od: Clemens Warnke, i dr.
Izdano: (2010)

Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey
od: Tjalf Ziemssen, i dr.
Izdano: (2021)

The telemedicine community readiness model-successful telemedicine implementation and scale-up
od: Lena Otto, i dr.
Izdano: (2023)

Creating the 'New Europe' through Postal Services Setting Postal Standards during World War II
od: Proschmann, Sabrina
Izdano: (2022)

Entmietet und verdrängt Wie Mieter*innen ihren Wohnungsverlust erleben
od: Meuth, Miriam
Izdano: (2023)

Entmietet und verdrängt Wie Mieter*innen ihren Wohnungsverlust erleben
od: Meuth, Miriam
Izdano: (2023)

The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing-Remitting and Secondary Progressive Multiple Sclerosis
od: Martin Vališ, i dr.
Izdano: (2023)

Expert consensus statement on therapeutic drug monitoring and individualization of linezolid
od: Bin Lin, i dr.
Izdano: (2022)

EMAST Instability and CHEK2 Promoter Analysis in Colorectal Cancer
od: S Rezapour, i dr.
Izdano: (2005)

EMAST Instability and CHEK2 Promoter Analysis in Colorectal Cancer
od: S Rezapour, i dr.
Izdano: (2005)

Monitoring the transition of patients on biologics in rheumatoid arthritis: Consensus guidance for pharmacists
od: Denis Choquette, i dr.
Izdano: (2021)

Challenges in monitoring the quality of care in multiple sclerosis
od: Uwe Klaus Zettl, i dr.
Izdano: (2024)

Consensus statement on the management of breakthrough cancer pain: Assessment, treatment and monitoring recommendations
od: María Dolores López Alarcón, i dr.
Izdano: (2019)

Brazilian Consensus on Photoprotection
od: Sérgio Schalka, i dr.
Izdano: (2014)

Rituximab mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis
od: Tobias Zrzavy, i dr.
Izdano: (2021)

Measuring community norms around women's empowerment in the West Bank: Opportunities and challenges of a novel approach using cultural consensus
od: Roseanne C. Schuster, i dr.
Izdano: (2019)

Editorial: Scaling-up health-IT-sustainable digital health implementation and diffusion
od: Hannes Schlieter, i dr.
Izdano: (2024)

Commentary: Revised contraindications for the use of non-medical WB-electromyostimulation. Evidence-based German consensus recommendations
od: Dejan Reljic, i dr.
Izdano: (2024)

MetaCNV - a consensus approach to infer accurate copy numbers from low coverage data
od: Stefanie Friedrich, i dr.
Izdano: (2020)

Consensus or Conflict? China and Globalization in the 21st Century /
Izdano: (2021)

Consensus or Conflict? China and Globalization in the 21st Century
Izdano: (2021)

Consensus or Conflict? China and Globalization in the 21st Century
Izdano: (2021)

Development, and evaluation of drug monitoring system for multiple sclerosis patients
od: Reza Safdari, i dr.
Izdano: (2021)

Archäologische Untersuchungen Über Temporalität und Dinge
od: Stabrey, Undine
Izdano: (2017)

Archäologische Untersuchungen Über Temporalität und Dinge
od: Stabrey, Undine
Izdano: (2017)

Consensus statement on the management of urticaria
od: Kiran V Godse, i dr.
Izdano: (2011)

Data sharing: reaching consensus
od: Jimmy Whitworth
Izdano: (2010)

Consensus on topics for preceptor training
od: Lizemari Hugo-Van Dyk, i dr.
Izdano: (2021)

Expert Consensus on Photosensitive Epilepsies
od: J Gordon Millichap
Izdano: (2005)